2018 - 6 Issue

Case report

Idiopathic Chodoidal Neovascular Membrane in a 12-year-old Girl

Full Text links

Summary

Choroidal neovascularization (CNV) is a rare but serious cause of visual impairment in children.
The case report of a girl with a unilateral classical choroidal neovascular membrane has been presented. The differential diagnosis of possible etiology and the clinical course of this sight threatening condition during treatment have been documented. The similar cases in pediatric patients in foreign literature have been discussed.
Current anti VEGF therapy is also available for pediatric patients and play a key role in improvement and stabilization of visual acuity in children with this disease.

References

  1. Barth, T., Zeman, F., Helbig, H. et al.: Etiology and treatment of choroidal neovascularization in pediatric patients. Eur J Ophthalmol, 26(5); 2016: 388-93.
  2. Carneiro, AM., Silva, RM., Veludo, MJ. et al.: Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia. Ophthalmologica, 225(2); 2011: 81-88.
  3. Chhablani, J., Jalali, S.: Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child. Eur J Ophthalmol, 22(4); 2012: 677-679.
  4. Cohen, SY., Laroche, A., Leguen, Y. et al.: Etiology of choroidal neovascularization in young patients. Ophthalmology, 103(8);
  5. Giansanti, F., Virgili, G., Varano, M., et al.: Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina, 25(5); 2015: 590-596.
  6. Goshorn, EB., Hoover, DL., Eller, AW. et al.: Subretinal neovascularization in children and adolescents. J Pediatr Ophthalmol Strabismus, 32(3); 1995: 178-182.
  7. Jain, K., Shafiq, AE., Devenyi, RG.: Surgical outcome for re - moval of subfoveal choroidal neovascular membranes in children. Retina, 22; 2002: 412–417.
  8. Kim, R., Kim, YC.: Intravitreal ranibizumab injection for idi - opathic choroidal neovascularization in children. Semin Ophthalmol, 29(3); 2014: 178-181.
  9. Lipski, A., Bornfeld, N., Jurklies, B.: Photodynamic therapy with verteporfin in paediatric and young adult patients: longterm treatment results of choroidal neovascularisations. Br J Ophthalmol, 92(5); 2008: 655-660.
  10. Mimouni, KF., Bressler, SB., Bressler, NM.: Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. Am J Ophthalmol, 135(6); 2003: 900-902.
  11. Rishi, P., Gupta, A, Rishi, E. et al.: Choroidal neovascularization in 36 eyes of children and adolescents. Eye, 27(10); 2013: 1158-68
  12. Sisk, RA., Berrocal, AM., Albini, TA. et al.: Bevacizumab for the treatment of pediatric retinal and choroidal diseases. Ophthalmic Surg Lasers Imaging, 41(6); 2010: 582-592.
  13. Sivaprasad, S., Moore, AT.: Choroidal neovascularisation in children. Br J Ophthalmol, 92(4); 2008: 451-454.
  14. Spaide, RF.: Choroidal neovascularization in younger patients. Curr Opin Ophthalmol, 10(3); 1999: 177-181.
  15. Wilson, ME., Mazur, DO.: Choroidal neovascularization in children: report of five cases and literature review. J Pediatr Ophthalmol Strabismus, 25(1); 1088: 23-29.